drugset / Trial / NCT06601192
A Study to Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy Adults
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of the study is to assess the effect of a therapeutic and supratherapeutic dose of zelicapavir on the corrected cardiac QT interval relative to a placebo and positive control in healthy participants.
Timeline
- Start
- 2024-07-15
- Primary completion
- 2025-02-02
- Completion
- 2025-02-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Moxifloxacin | Small molecule | — | — |
| Subject | zelicapavir | Small molecule | — | — |